A low CFB expression has been associated with a poor overall survival and a more aggressive disease in different solid tumors, including lung adenocarcinoma [36] and pancreatic ductal adenocarcinoma [35]. This evidence concerns the gene CFB and pancreatic ductal adenocarcinoma.